These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32927497)

  • 1. Drug screening platform using human induced pluripotent stem cell-derived atrial cardiomyocytes and optical mapping.
    Gunawan MG; Sangha SS; Shafaattalab S; Lin E; Heims-Waldron DA; Bezzerides VJ; Laksman Z; Tibbits GF
    Stem Cells Transl Med; 2021 Jan; 10(1):68-82. PubMed ID: 32927497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Ventricular and Atrial Cardiomyocyte Subtypes from Human-Induced Pluripotent Stem Cells.
    Nakanishi-Koakutsu M; Takaki T; Miki K; Yoshida Y
    Methods Mol Biol; 2021; 2320():135-149. PubMed ID: 34302655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chamber-specific contractile responses of atrial and ventricular hiPSC-cardiomyocytes to GPCR and ion channel targeting compounds: A microphysiological system for cardiac drug development.
    Lickiss B; Hunker J; Bhagwan J; Linder P; Thomas U; Lotay H; Broadbent S; Dragicevic E; Stoelzle-Feix S; Turner J; Gossmann M
    J Pharmacol Toxicol Methods; 2024; 128():107529. PubMed ID: 38857637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD151 expression marks atrial- and ventricular- differentiation from human induced pluripotent stem cells.
    Nakanishi-Koakutsu M; Miki K; Naka Y; Sasaki M; Wakimizu T; Napier SC; Okubo C; Narita M; Nishikawa M; Hata R; Chonabayashi K; Hotta A; Imahashi K; Nishimoto T; Yoshida Y
    Commun Biol; 2024 Feb; 7(1):231. PubMed ID: 38418926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial-specific hiPSC-derived cardiomyocytes in drug discovery and disease modeling.
    Gharanei M; Shafaattalab S; Sangha S; Gunawan M; Laksman Z; Hove-Madsen L; Tibbits GF
    Methods; 2022 Jul; 203():364-377. PubMed ID: 34144175
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Rodríguez NA; Patel N; Dariolli R; Ng S; Aleman AG; Gong JQX; Lin HM; Rodríguez M; Josowitz R; Sol-Church K; Gripp KW; Lin X; Song SC; Fishman GI; Sobie EA; Gelb BD
    Circ Arrhythm Electrophysiol; 2024 Apr; 17(4):e012022. PubMed ID: 38415356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Same-Single-Cell Analysis of Pacemaker-Specific Markers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Subtypes Classified by Electrophysiology.
    Yechikov S; Copaciu R; Gluck JM; Deng W; Chiamvimonvat N; Chan JW; Lieu DK
    Stem Cells; 2016 Nov; 34(11):2670-2680. PubMed ID: 27434649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic Characterization of Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes.
    Argenziano M; Lambers E; Hong L; Sridhar A; Zhang M; Chalazan B; Menon A; Savio-Galimberti E; Wu JC; Rehman J; Darbar D
    Stem Cell Reports; 2018 Jun; 10(6):1867-1878. PubMed ID: 29731429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patch-Clamp Recording from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Improving Action Potential Characteristics through Dynamic Clamp.
    Verkerk AO; Veerman CC; Zegers JG; Mengarelli I; Bezzina CR; Wilders R
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human-induced pluripotent stem cell-atrial-specific cardiomyocytes and atrial fibrillation.
    Leowattana W; Leowattana T; Leowattana P
    World J Clin Cases; 2022 Sep; 10(27):9588-9601. PubMed ID: 36186184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilizing human induced pluripotent stem cells to study atrial arrhythmias in the short QT syndrome.
    Shiti A; Arbil G; Shaheen N; Huber I; Setter N; Gepstein L
    J Mol Cell Cardiol; 2023 Oct; 183():42-53. PubMed ID: 37579942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational models of ventricular- and atrial-like human induced pluripotent stem cell derived cardiomyocytes.
    Paci M; Hyttinen J; Aalto-Setälä K; Severi S
    Ann Biomed Eng; 2013 Nov; 41(11):2334-48. PubMed ID: 23722932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
    Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
    Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial-like Engineered Heart Tissue: An In Vitro Model of the Human Atrium.
    Lemme M; Ulmer BM; Lemoine MD; Zech ATL; Flenner F; Ravens U; Reichenspurner H; Rol-Garcia M; Smith G; Hansen A; Christ T; Eschenhagen T
    Stem Cell Reports; 2018 Dec; 11(6):1378-1390. PubMed ID: 30416051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Cell RNA-Sequencing and Optical Electrophysiology of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Discordance Between Cardiac Subtype-Associated Gene Expression Patterns and Electrophysiological Phenotypes.
    Biendarra-Tiegs SM; Li X; Ye D; Brandt EB; Ackerman MJ; Nelson TJ
    Stem Cells Dev; 2019 May; 28(10):659-673. PubMed ID: 30892143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia.
    Thorpe J; Perry MD; Contreras O; Hurley E; Parker G; Harvey RP; Hill AP; Vandenberg JI
    Stem Cell Res Ther; 2023 Jul; 14(1):183. PubMed ID: 37501071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation profiling allows for characterization of atrial and ventricular cardiac tissues and hiPSC-CMs.
    Hoff K; Lemme M; Kahlert AK; Runde K; Audain E; Schuster D; Scheewe J; Attmann T; Pickardt T; Caliebe A; Siebert R; Kramer HH; Milting H; Hansen A; Ammerpohl O; Hitz MP
    Clin Epigenetics; 2019 Jun; 11(1):89. PubMed ID: 31186048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrarapid Delayed Rectifier K
    Hilderink S; Devalla HD; Bosch L; Wilders R; Verkerk AO
    Front Cell Dev Biol; 2020; 8():536. PubMed ID: 32850774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.